Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility

1. Scientific Background and Clinical Need

Infertility affects approximately one in six couples worldwide. In up to 40 percent of cases, no clear etiology can be identified even after comprehensive clinical and laboratory evaluation, a condition traditionally defined as idiopathic infertility. In parallel, a growing number of women experience persistent reproductive failure despite adequate management of identifiable conditions such as endometriosis, polycystic ovary syndrome, or hormonal imbalance. This category, referred to as post-treatment unexplained or functionally idiopathic infertility, includes patients whose anatomical and endocrine parameters appear normalized, yet who continue to experience repeated ART failures, whether through intrauterine insemination or in vitro fertilization.

Both idiopathic and post-treatment unexplained infertility reveal a fundamental limitation of current diagnostic frameworks. Conventional assessments may normalize structural or hormonal parameters while overlooking deeper molecular dysfunctions that impair reproductive capacity.

Emerging evidence suggests that many of these cases correspond to an unrecognized form of reproductive aging, in which cellular and molecular decline within reproductive tissues occurs earlier than chronological aging would predict. In other words, the reproductive system becomes biologically older than the patient's calendar age.

Conventional diagnostic tools primarily assess quantitative and structural parameters such as hormonal levels, oocyte count, uterine morphology, or tubal patency. However, these metrics fail to capture the qualitative dimensions of cellular health, particularly those associated with the hallmarks of aging such as telomere erosion, mitochondrial dysfunction, and cellular senescence.

This diagnostic gap underscores the need for molecular biomarkers capable of reclassifying idiopathic infertility into a biologically defined and actionable condition, enabling both mechanistic understanding and targeted therapeutic intervention. 2. The Hallmarks of Aging and the Central Role of Telomeres

Aging is now understood through the framework of biological hallmarks, a unified model describing the processes that collectively drive functional decline. These hallmarks are categorized into primary, secondary, and tertiary groups:

2.1. Primary hallmarks: the initiating sources of molecular damage, including genomic instability, telomere attrition, epigenetic alterations, and loss of proteostasis.

2.2. Secondary hallmarks: the cellular responses to this damage, such as mitochondrial dysfunction, cellular senescence, and deregulated nutrient sensing.

2.3. Tertiary hallmarks: the downstream manifestations of chronic cellular stress, including altered intercellular communication and chronic inflammation.

This hierarchy functions as a domino-like system, in which the perturbation of the primary hallmarks initiates secondary and tertiary responses that progressively erode tissue homeostasis and ultimately lead to age-related disease. When this process unfolds in the brain, it manifests as neurodegeneration; when it occurs in the ovaries, it accelerates reproductive aging and loss of fertility.

At the base of this biological network lies telomere biology, which serves as both a sensor and structural foundation of cellular aging. Among all primary hallmarks, telomere attrition occupies a pivotal and initiating position, as it represents the most direct and quantifiable indicator of cumulative molecular stress. Its destabilization propagates dysfunction across multiple downstream hallmarks, activating mitochondrial decline, genomic instability, cellular senescence, and chronic inflammation. In this sense, telomere erosion forms the base of the aging cascade, upon which secondary and tertiary hallmarks unfold, eventually leading to age-related diseases when the process remains uncorrected. 3. Telomere

Imagine the genome as a book, with telomeres serving as its protective covers, keeping the pages intact and preventing them from fraying. With each cell division, these covers naturally wear down in somatic cells, where telomerase activity is limited to absent, making gradual telomere shortening an intrinsic feature of cellular aging. In contrast, germline cells and certain stem cell populations express telomerase and other maintenance mechanisms that help preserve telomere length, ensuring genomic stability across generations.

However, when oxidative stress or replicative demand exceeds repair capacity, telomere erosion accelerates even in these lineages, compromising chromosomal integrity. As telomeres, the book covers, shorten, the remaining DNA, including the coding genome, which represents about one percent of total DNA, becomes increasingly susceptible to strand breaks, instability, and loss. This phenomenon is systemically reflected in leukocytes, where telomere length provides a measurable proxy for biological aging and cumulative molecular stress across tissues.

This conceptual analogy translates directly into molecular reality. Telomeres are repetitive DNA sequences located at the tips of chromosomes, where they preserve genome integrity by preventing end-to-end fusions and inappropriate DNA repair signaling. When telomeres become critically short, cells lose their ability to divide safely. Under normal circumstances, such cells either activate repair pathways or undergo programmed cell death (apoptosis).

When these safety mechanisms fail, cells enter senescence, a non-dividing yet metabolically active state. Senescent cells release inflammatory cytokines and reactive oxygen species, gradually creating a microenvironment of chronic inflammation and oxidative stress. One of the earliest and most profound consequences of this state is mitochondrial decline, a process intimately linked to the telomere damage response pathway. Dysfunctional telomeres trigger persistent DNA damage signaling that alters mitochondrial biogenesis and energy metabolism through the p53-PGC-1α axis, leading to reduced ATP production, elevated reactive oxygen species, and further telomere erosion. Over time, this self-reinforcing loop between telomere instability and mitochondrial dysfunction erodes tissue homeostasis, impairs organ performance, and contributes to the progression of age-related diseases. Thus, telomere shortening is not merely a marker of aging, it is a causal driver of biological decline, linking genomic instability, mitochondrial failure, and systemic dysfunction.

In reproductive medicine, the decline in fertility is not determined solely by the number of gametes but by their quality, which depends on the health of their surrounding microenvironment. In the context of this clinical study, which focuses on women, this principle is illustrated through the biology of the oocyte and its companion somatic cells. One major determinant of oocyte quality is telomere erosion within granulosa cells, which orchestrate follicular maturation and provide the molecular and metabolic support necessary for meiotic progression. These cells synthesize growth factors, cytokines, and mitochondrial substrates essential for chromosomal stability and cytoplasmic competence. When telomeres in granulosa cells become critically short, the resulting telomere damage response disrupts transcriptional regulation and mitochondrial function, reducing the production of proteins and signaling molecules required for oocyte maturation. As a result, the ovarian reserve may appear quantitatively normal, yet fertilization and embryonic development fail due to impaired oocyte quality.

Recent studies have shown that shortened telomeres or reduced telomerase activity in granulosa cells correlate with poor oocyte maturation, lower fertilization rates, and diminished embryo quality, even among young women with normal hormonal profiles. This suggests that premature telomere attrition represents a hidden molecular etiology of infertility, where accelerated cellular aging within the follicular niche compromises reproductive potential.

A similar process occurs directly within oocytes, which are exceptionally long-lived germ cells formed during fetal development and maintained in meiotic arrest for decades. This prolonged quiescence makes them uniquely vulnerable to the cumulative effects of oxidative stress and telomere erosion. As telomeres in oocytes progressively shorten or become structurally unstable, checkpoint pathways are activated, leading to errors in chromosomal segregation, spindle abnormalities, and reduced fertilization potential. Telomere damage also disrupts mitochondrial homeostasis and ATP production, impairing cytoplasmic maturation and early embryonic development. Thus, telomere attrition within oocytes represents a cell-intrinsic mechanism of reproductive aging, complementing the somatic contribution of granulosa cell dysfunction and jointly determining overall oocyte quality. 4. Telomeres as etiology Biomarkers of Reproductive Aging

Telomeres have been increasingly validated by scientific evidence as qualitative biomarkers of reproductive cellular aging, capturing both the extent and the pattern of molecular decline. Beyond their absolute length, it is the architecture and distribution of telomere lengths across individual cells, and particularly the presence and frequency of critically short telomeres, that define a distinct molecular signature of cellular aging.

Such signatures cannot be captured through population-averaged measurements, as they only emerge when telomeres are analyzed cell by cell, revealing the intrinsic heterogeneity that determines genomic stability and biological integrity. These distributional profiles serve as early indicators of molecular imbalance: when a subset of cells accumulates ultra-short telomeres, it uncovers the onset of genomic instability and mitochondrial decline long before mean telomere values begin to change.

Despite this growing understanding, most studies assessing telomere length in infertility have relied on population-averaged techniques such as quantitative PCR (qPCR) or Southern blot. These methods provide only a single mean value across hundreds of cells, masking the subset harboring critically short telomeres, the true initiators of genomic instability, mitochondrial failure, and cellular senescence.

Moreover, qPCR-based assays suffer from technical variability, including amplification bias, primer inefficiency, and normalization errors, further diluting biological precision. Consequently, the inconsistencies reported in clinical findings reflect not the invalidity of telomere biology, but the limitations of low-resolution technologies incapable of detecting the true pathological pattern.

To overcome these constraints, this clinical study employs the BEYOND GENOMiX patented single-cell fluorescence in situ hybridization (FISH) protocol, which quantifies telomere length at cellular resolution in leukocytes obtained from peripheral blood. This approach yields both quantitative and qualitative data, mapping the full telomere-length spectrum, exposing cell-to-cell variability, and identifying the subset of cells with critically short telomeres invisible to bulk assays. Results are interpreted individually and benchmarked against age-matched healthy reference ranges.

The resulting telomere signature is defined by three complementary parameters:

4.1 Average Telomere Length

Average telomere length has long been used as a basic metric of cellular aging. It provides an estimate of biological age, but it remains limited: two individuals may display identical mean telomere lengths while exhibiting markedly different cellular and clinical outcomes. This discrepancy arises because average measurements obscure the critical subset of cells harboring extremely short telomeres, those most responsible f

• Change in Percentage of Critically Short Telomeres (<5 kb) [Time frame: Assessed from baseline to 3 months after initiation of the integrative intervention; participants without sufficient biological response at 3 months may undergo a second assessment at 6 months.]
• Change in Telomere Length Distribution Profile [Time frame: Assessed from baseline to 3 months after initiation of the integrative intervention; participants without sufficient biological response at 3 months may undergo a second assessment at 6 months.]
• Change in Mean Leukocyte Telomere Length [Time frame: From baseline to 3 months after initiation of the integrative intervention, with an additional assessment at 6 months if the biological response at 3 months is insufficient.]
• Change in Serum Anti-Müllerian Hormone (AMH) Level [Time frame: From baseline to 3 months after initiation of the integrative intervention, with an additional assessment at 6 months if the biological response at 3 months is insufficient.]
• Change in Serum Follicle-Stimulating Hormone (FSH) Level [Time frame: From baseline to 3 months after initiation of the integrative intervention, with an additional assessment at 6 months if the biological response at 3 months is insufficient.]
• Change in Antral Follicle Count (AFC) [Time frame: Assessed from baseline to 3 months after initiation of the integrative intervention; participants without sufficient biological response at 3 months may undergo a second assessment at 6 months.]
• Safety and Tolerability of the Integrative Intervention [Time frame: From initiation of the integrative intervention through study completion (up to 12 months).]